z-logo
open-access-imgOpen Access
BORTEZOMIB EXHIBITS THERAPEUTIC IMPLICATION IN RENAL INTERSTITIAL FIBROSIS AFTER KIDNEY TRANSPLANTATION BY INHIBITING AKT-MTOR-P70S6K-SMURF2 PATHWAY AND STABILIZING IΚBΑ PROTEIN
Author(s) -
Chuanjian Suo,
Hao Chen,
Li Sun,
Zijie Wang,
Zhijian Han,
Jun Tao,
Xiaobing Ju,
Ruoyun Tan,
Min Gu
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000699072.47861.bc
Subject(s) - bortezomib , cancer research , epithelial–mesenchymal transition , protein kinase b , transplantation , medicine , pi3k/akt/mtor pathway , fibrosis , kidney , proteasome inhibitor , signal transduction , chemistry , pathology , biology , multiple myeloma , microbiology and biotechnology , cancer , metastasis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom